GSK acquires Nuvalent for $10.6 billion to rebuild its oncology business
2 hours ago · Crypto Briefing
GSK’s acquisition of Nuvalent signals a strategic pivot towards oncology, potentially reshaping its market position and investor dynamics. The post GSK acquires Nuvalent for $10.6 billion to rebuild its oncology business appeared firs...
